Cargando…
Cerebral venous sinus thrombosis following intracerebral hemorrhage after COVID‐19 AstraZeneca vaccination: A case report
The patient was a 55‐year‐old female patient who presented with sudden onset of left hemiplegia, facial hemiparesis, and hypoesthesia. She has received her first dose of the AstraZeneca COVID‐19 vaccine. This case indicates that vaccination may raise the hypercoagulable state even in a condition of...
Autores principales: | Haj Mohamad Ebrahim Ketabforoush, Arsh, Molaverdi, Ghazale, Nirouei, Matineh, Abbasi Khoshsirat, Nahid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664546/ https://www.ncbi.nlm.nih.gov/pubmed/36397844 http://dx.doi.org/10.1002/ccr3.6505 |
Ejemplares similares
-
Acute polyneuropathy as the main manifestation of primary Sjogren’s syndrome: A case report
por: Haj Mohamad Ebrahim Ketabforoush, Arsh, et al.
Publicado: (2022) -
Thrombocytopenia and Intracranial Venous Sinus Thrombosis after “COVID-19 Vaccine AstraZeneca” Exposure
por: Wolf, Marc E., et al.
Publicado: (2021) -
AstraZeneca COVID-19 vaccine: thrombosis with thrombocytopenia
Publicado: (2021) -
AstraZeneca COVID-19 vaccine-related thrombocytopenia and thrombosis
Publicado: (2021) -
IgG4‐related disease associated with the primary manifestation of recurrent cerebral venous thrombosis: A rare case report
por: Haj Mohamad Ebrahim Ketabforoush, Arsh, et al.
Publicado: (2022)